Tidal Investments’s Filana Therapeutics FLNA Stock Holding History

Tidal Investments’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-375,000	Closed	-$11M	–	1967
2024 Q3	$11M	Buy	+375,000	New	+$8.64M	0.12%	163

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Tidal Investments's FLNA Position: Q4 2024 in Review

Tidal Investments sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 375,000 shares — an estimated $11M sold.

Tidal Investments first reported a position in FLNA in Q3 2024 and held it in 1 quarter. The position peaked at $11M in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

Tidal Investments reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
Tidal Investments sold 375,000 Filana Therapeutics shares in Q4 2024, an estimated $11M.
Tidal Investments first reported a position in Filana Therapeutics in Q3 2024 and held it in 1 quarter.
Tidal Investments's Filana Therapeutics position peaked at $11M in Q3 2024.
137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Tidal Investments's 13F filing for Q4 2024, filed 14 Feb 2025.